Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2550]

WCLC 2022: Study discloses clinical-relevant intertumoural heterogeneity of NSCLC driven by MET exon 14 skipping

WCLC 2022: Study discloses clinical-relevant intertumoural heterogeneity of NSCLC driven by MET exon 14 skipping

WCLC 2022: NELSON trial protocol more sensitive than National Lung Screening trial and may increase the benefits of lung cancer screening

WCLC 2022: NELSON trial protocol more sensitive than National Lung Screening trial and may increase the benefits...

WCLC 2022: National Lung Screening trial finds second primary lung cancer is 4 percent and as high as 8 percent among surgery patients

WCLC 2022: National Lung Screening trial finds second primary lung cancer is 4 percent and as high as 8 percent...

WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete pathological responders from NADIM trial

WCLC 2022: Tumour bulk-RNA sequence identifies NSCLC patients at high risk of progression in non-complete...

WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical activity for advanced KRAS p.G12C NSCLC

WCLC 2022: Sotorasib as a lead-in therapy with pembrolizumab or atezolizumab demonstrates durable clinical...

WCLC 2022: Sugemalimab a safe and effective consolidation therapy for unresectable stage III NSCLC

WCLC 2022: Sugemalimab a safe and effective consolidation therapy for unresectable stage III NSCLC

WCLC 2022: Early diagnosis of lung cancer among younger vs. older adults: widening disparities in the era of lung cancer screening

WCLC 2022: Early diagnosis of lung cancer among younger vs. older adults: widening disparities in the era of lung...

Protein that may predict future diabetes risk and death from cancer identified

Protein that may predict future diabetes risk and death from cancer identified

Improving serious illness communication for patients with advanced cancer

Improving serious illness communication for patients with advanced cancer

New combination therapy shows early promise against certain lung cancers

New combination therapy shows early promise against certain lung cancers

More from ecancer